The patient with abdominal aortic aneurysm (AAA) commonly is a nondiabetic, white man with a history of smoking. Moreover, AAA represents a leading cause of death in elderly men in Western countries. The purpose of this manuscript is to review current evidence as to the pathobiology of AAA as well as potential future drug targets to prevent progression of AAA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pcad.2007.05.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!